Fewer Prescribers Are Driving NBRx Than You Think—Here’s Why
According to a 2021 study by Statista, 40% of prescriptions written in 2005 were ...
Mindshift: Preparing the New, Truly Hybrid Salesforce
In his heyday, the pharma and life sciences sales representative enjoyed a level of ...
Reshaping Commercial Operations for COVID-Era Launch Success
Healthcare professionals’ jobs have become more difficult during the COVID-19 pandemic. In-person interactions with ...
4 Imperatives to Optimize the Pharma Sales Team in 2022
As pharma commercial and marketing teams plan for 2022 and examine their sales forces ...
Breaking the Rep Factory—There Is a Better Way
How can you as a pharma leader break the “rep factory” cycle to drive ...
What Does “Good” Engagement Look Like in a Hybrid World?
With the Delta variant now rapidly spreading across the country, commercial teams are once ...
Using Podcasting for Pharma Sales Enablement
The COVID-19 pandemic introduced new internal communication challenges, from onboarding new hires to training ...
The Complicated Art of Marketing and Selling in an Account-based Environment
It’s easy to blame the pandemic for disruptions in pharmaceutical sales. Without boots on ...
4 Ways to Shape Your Sales Team for Success Post-Pandemic
The ability to engage physicians through marketing and sales efforts has grown more challenging ...
Opportunity’s Knocking: Open the Door to These Next-Gen Field Team Strategies
Information symmetry between field sales representatives and customers has arrived. In most cases, healthcare ...
Unlock Digital Excellence in Commercial with Quality Customer Data
As the industry navigates COVID-19, one thing has become clear—life sciences companies with access ...
Virtual Engagements: What Works, What Doesn’t, and What’s New?
When pharma companies called their sales forces in from the road last March due ...
2021: A “Tale of Two Cities” for the Pharma Industry
Uncertainty was the prevailing theme of 2020 across nearly every sector and business function ...
